US health reform bill will hinder introduction of generic forms of biological drugs, critics sayBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b4088 (Published 06 October 2009) Cite this as: BMJ 2009;339:b4088
- Janice Hopkins Tanne
- 1New York
Medical students and consumer groups in the United States have objected to parts of the proposed healthcare reform bills, which they say will make it more difficult to introduce cheap generic forms of biological drugs (drugs derived biologically rather than chemically).
The American Medical Students Association and the consumer groups Universities Allied for Essential Medicines, Essential Action, and Knowledge Ecology International say that provisions in several Senate and House of Representatives healthcare reform bills will block the introduction of most generic biologicals. Improving the proposed bills could save $71bn (£45bn; €49bn) …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial